Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,960.00    2.00 (0.05%)
Bid:
3,926.00
Ask:
3,930.00
Spread: 4.00 (0.102%)
Market Cap: £14.96b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Directorate Change

15 Nov 2021 07:00

RNS Number : 2772S
Halma PLC
15 November 2021
 

Halma plc ("Halma")

 

Appointment of independent non-executive Director

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Sharmila Nebhrajani OBE as an independent non-executive Director, effective 1 December 2021. Sharmila will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Sharmila brings a wealth of experience gained across a variety of roles - spanning both the public and private/NGO sectors - with a particularly strong background in sustainability and health. She is currently a non-executive director at ITV plc and Severn Trent plc, and Chair of the National Institute for Health and Care Excellence (NICE).Sharmila was Chief Executive of Wilton Park (part of the Foreign and Commonwealth Office), responsible for convening international policy dialogue with governments, NGOs, policy makers and academics on topics such as global health and climate risk. Previously, she worked for the Medical Research Council, Association of Medical Research Charities and NHS Sussex. In her earlier career, she held senior positions within the BBC, Cable & Wireless plc and PwC.

Dame Louise Makin, Chair, commented: "I am delighted that Sharmila has agreed to join the Halma Board. Her diverse experience, particularly in the health and medical sector, will undoubtedly bring a fresh perspective and valuable insights to the Board."

 

There are no further details to be disclosed for Sharmila Nebhrajani under Listing Rule 9.6.13R.

 

For further information, please contact:

 

Halma plc

Andrew Williams, Group Chief Executive

+44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations

+44 (0)7776 685948

Clayton Hirst, Director of Corporate Affairs

+44 (0)7384 796013

 

MHP Communications

Andrew Jaques / Rachel Farrington

+44 (0)20 3128 8788

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Notes

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

· Safety: protecting life as populations grow and protecting worker safety.

· Environment: improving food and water quality, and monitoring air pollution.

· Health: meeting rising healthcare demand as growing populations age and lifestyles change.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

In January 2021, Halma was named Britain's Most Admired Company by Management Today.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMMMDZVGMZM
Date   Source Headline
9th Sep 20054:41 pmRNSHolding(s) in Company
2nd Sep 20057:00 amRNSAdoption of IFRS
12th Aug 20059:32 amRNSDirector/PDMR Shareholding
11th Aug 20059:15 amRNSAcquisition
10th Aug 20053:23 pmRNSDirector/PDMR Shareholding
9th Aug 20052:30 pmRNSDirector/PDMR Shareholding
5th Aug 200512:44 pmRNSResult of AGM
3rd Aug 20057:00 amRNSAGM Statement
29th Jul 20054:53 pmRNSBlocklisting Interim Review
27th Jul 200511:11 amRNSHolding(s) in Company
22nd Jul 20054:05 pmRNSAnnual Information Update
19th Jul 20051:24 pmRNSAcquisition
12th Jul 20054:16 pmRNSDirector/PDMR Shareholding
12th Jul 20052:55 pmRNSHolding(s) in Company
6th Jul 20054:37 pmRNSDirector/PDMR Shareholding
5th Jul 20055:16 pmRNSAnnual Report and Accounts
1st Jul 20054:45 pmRNSHolding(s) in Company
29th Jun 20059:56 amRNSDirector Shareholding
24th Jun 20054:53 pmRNSDirector Shareholding
21st Jun 20057:00 amRNSFinal Results
6th Jun 20059:51 amRNSNotice of Board Meeting
28th Apr 20057:00 amRNSTrading Statement
1st Mar 20057:00 amRNSDirectorate Change
8th Feb 200510:15 amRNSDirector Shareholding
17th Jan 20059:30 amRNSBlocklisting Interim Review
17th Jan 20059:26 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.